butabarbital decreases effects of sufentanil SL by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Modify Therapy/Check Carefully. Coadministration of CYP3A4 inducers may lower sufentanil degrees and efficacy, maybe precipitating withdrawal syndrome in patients who may have designed Bodily dependence to sufentanil. Discontinuation of concomi